UK-based cell-line engineering firm iotaSciences has announced an exclusive partnership with Quantum Design China, a subsidiary of US-based Quantum Design International. Under this agreement, Quantum Design will provide distribution services for iotaSciences’ proprietary single-cell handling platforms within China.
iotaSciences’ Single Cell Handling Technologies and Their Applications
iotaSciences specializes in the production of single cell handling technologies that offer unique capabilities for cell biology and gene therapy development. These technologies serve academic and industrial scientists in the life science market, playing a crucial role in advancing scientific research and development. The company’s technology advantages include automation for isolating single cells, providing documented proof of monoclonality based on whole-well images. This feature is particularly beneficial for accelerating the development of stable cell lines, such as genome-edited induced pluripotent stem cells (iPSCs) and viral vector producing cells.
Implications of the Partnership for the Life Science Market
The partnership between iotaSciences and Quantum Design China is set to enhance the accessibility of iotaSciences’ innovative single-cell handling platforms in the Chinese market. This collaboration will likely contribute to the growth of the life science industry in China by providing cutting-edge tools for cell biology research and gene therapy development.-Fineline Info & Tech
